Back to Search Start Over

Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis.

Authors :
Ortiz-Espinosa S
Morales X
Senent Y
Alignani D
Tavira B
Macaya I
Ruiz B
Moreno H
Remírez A
Sainz C
Rodriguez-Pena A
Oyarbide A
Ariz M
Andueza MP
Valencia K
Teijeira A
Hoehlig K
Vater A
Rolfe B
Woodruff TM
Lopez-Picazo JM
Vicent S
Kochan G
Escors D
Gil-Bazo I
Perez-Gracia JL
Montuenga LM
Lambris JD
Ortiz de Solorzano C
Lecanda F
Ajona D
Pio R
Source :
Cancer letters [Cancer Lett] 2022 Mar 31; Vol. 529, pp. 70-84. Date of Electronic Publication: 2021 Dec 28.
Publication Year :
2022

Abstract

Myeloid-derived suppressor cells (MDSCs) play a major role in cancer progression. In this study, we investigated the mechanisms by which complement C5a increases the capacity of polymorphonuclear MDSCs (PMN-MDSCs) to promote tumor growth and metastatic spread. Stimulation of PMN-MDSCs with C5a favored the invasion of cancer cells via a process dependent on the formation of neutrophil extracellular traps (NETs). NETosis was dependent on the production of high mobility group box 1 (HMGB1) by cancer cells. Moreover, C5a induced the surface expression of the HMGB1 receptors TLR4 and RAGE in PMN-MDSCs. In a mouse lung metastasis model, inhibition of C5a, C5a receptor-1 (C5aR1) or NETosis reduced the number of circulating-tumor cells (CTCs) and the metastatic burden. In support of the translational relevance of these findings, C5a was able to stimulate migration and NETosis in PMN-MDSCs obtained from lung cancer patients. Furthermore, myeloperoxidase (MPO)-DNA complexes, as markers of NETosis, were elevated in lung cancer patients and significantly correlated with C5a levels. In conclusion, C5a induces the formation of NETs from PMN-MDSCs in the presence of cancer cells, which may facilitate cancer cell dissemination and metastasis.<br /> (Copyright © 2021 Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1872-7980
Volume :
529
Database :
MEDLINE
Journal :
Cancer letters
Publication Type :
Academic Journal
Accession number :
34971753
Full Text :
https://doi.org/10.1016/j.canlet.2021.12.027